Neuroone Medical Technologies's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Neuroone Medical Technologies's ROA in the second quarter of 2026?
Neuroone Medical Technologies Corp recorded a cumulative net loss of $-7 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -66.89%.

However, within the Healthcare sector 648 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2026 quarter, so far to 4090, from total ROA ranking in the first quarter of 2025 at 4831.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Mar 31 2026) II. Quarter	(Dec 31 2025) I. Quarter	(Sep 30 2025) IV. Quarter	(Jun 30 2025) III. Quarter	(Mar 31 2025) II. Quarter
Y / Y Total Assets Change	64.6 %	-75.69 %	119.55 %	100.55 %	-44.96 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-7	-7	-4	-5	-6
Return On Assets (TTM)	-66.89 %	-74.13 %	-20.48 %	-29.45 %	-41.32 %
NMTC's Total Ranking	# 4090	# 4831	# 3984	# 4297	# 4602
Total Assets (TTM) in million	7	11	11	11	4
Seq. Total Assets Change	-31.99 %	0 %	-0.31 %	142.77 %	-89.96 %
Seq. Net Income Change	-	-	-	-	-

NMTC's 5 Years Annual ROA >> Back to NMTC Management Effectiveness >> Compare NMTC ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 154
Sector	# 649
Overall	# 4055

Return On Assets Statistics
High	Average	Low
-45.88 %	-106.53 %	-187.28 %
(Sep 30 2025)		(Mar 31 2024)

Financial Statements
Neuroone Medical Technologies's Assets	$ 7 million	NMTC's Balance sheet
Neuroone Medical Technologies's Income	$ -2 million	Quarterly NMTC's Income Statement
NMTC's Income by Division		See NMTC's Income by Division

Annual Return On Assets	(Sep 30 2025) FY 2025	(Sep 30 2023) FY 2023	(Sep 30 2022) FY 2022	(Sep 30 2021) FY 2021	(Jul 31 2015) FY 2015
Y / Y Total Assets Change	33.2 %	-36.85 %	61.52 %	47226.27 %	7887.62 %
Total Assets in million	11	8	13	8	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-4	-12	-10	-10	0
Annual Return On Assets	-33.43 %	-146.46 %	-77.98 %	-125.32 %	-180.73 %

NMTC's 5 Years Annual ROA >> Back to NMTC Management Effectiveness >> Compare NMTC ROA to its Competitors

More Return On Assets Ratios
NMTC's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
NMTC's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for NMTC's Competitors
Subscribers only: Roa for Neuroone Medical Technologies's Suppliers
Subscribers only: Return On Assets for NMTC's Customers

You may also want to know
NMTC's Roi	NMTC's Inventory Turnover Ratio	NMTC's Growth Rates	NMTC's Dividend Comparisons
	NMTC's Profitability Ratios	NMTC's Asset Turnover Ratio	NMTC's Dividend Growth
NMTC's Roe	NMTC's Valuation Ratios	NMTC's Financial Strength Ratios	NMTC's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2026, within Healthcare Sector

ROA

Date modified: 2026-09-18T10:53:40+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.